Synthesis of Complex Carbohydrates.

复杂碳水化合物的合成。

基本信息

  • 批准号:
    8826141
  • 负责人:
  • 金额:
    $ 28.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Within the realm of synthetic carbohydrate chemistry, the stereoselective formation of glycosidic bonds is of paramount importance. Efficient manipulation of bond connectivity at the anomeric center opens up new approaches for the synthesis of complex carbohydrates, including the 1,2-cis-2-amino glycosides. These aminosugars make up one of the most important classes of naturally occurring oligosaccharides and glyco-conjugates, which play a crucial role as cell-surface receptor ligands for lectins, antibodies, and enzymes. However, progress toward understanding the specific functions of 1,2-cis-2-aminosugars has been hampered, due to the formidable challenge of obtaining an adequate supply of well-defined glycosides from natural sources. In many cases, high purity 1,2-cis-2-aminosugars can only be obtained by chemical synthesis, which also provides access to structural variants. Although there have been remarkable advances in the synthesis of 1,2-cis-2-amino glycosides, the disadvantages of current methodologies include the use of excess activating agents and unpredictable/poor anomeric selectivity. In this grant application, our goal is to develop a new and innovative strategy for the effective synthesis of 1,2-cis-2-amino glycosides via transition metal-catalyzed a-selective glycosylation (Specific Aim 1). The method that is currently being developed in our group will be broadly applicable and provide products in high yield and with excellent a-selectivity. The successful completion of the proposed method would have broad impact in the carbohydrate field, where catalytic methods for stereoselective glycosylation are still lacking. This transition-metal catalyzed 1,2-cis-2-amino glycosylation methodology will be applied to the synthesis of bioactive carbohydrate targets, including Campylobacter jejuni N-linked glycan (Specific Aim 2) which can be used to block Campylobacter jejuni adherence to human gastric epithelial cells and biding to mammalian lectins, and heparin oligosaccharides which have potent anticoagulant activity and minimal side effect (Specific Aim 3). 1
描述(由申请人提供):在合成碳水化合物化学领域,糖苷键的立体选择性形成是至关重要的。有效地控制端粒中心的键连通性为合成包括1,2-顺式-2-氨基糖苷在内的复杂碳水化合物开辟了新的途径。这些氨基糖构成了天然低聚糖和糖偶联物中最重要的一类,它们作为凝集素、抗体和酶的细胞表面受体配体起着至关重要的作用。然而,了解1,2-顺式-2-氨基糖的特定功能的进展受到阻碍,因为从天然来源获得足够的定义明确的糖苷是一项艰巨的挑战。在许多情况下,高纯度的1,2-顺-2-氨基糖只能通过化学合成获得,这也为结构变异提供了途径。虽然1,2-顺-2-氨基糖苷的合成已经取得了显著的进展,但现有方法的缺点包括使用过多的活化剂和不可预测/较差的端粒选择性。在这次拨款申请中,我们的目标是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hien M Nguyen其他文献

Hien M Nguyen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hien M Nguyen', 18)}}的其他基金

Development of Catalytic Glycosylations and Biologically Important Glycosaminoglycans
催化糖基化和具有生物学重要性的糖胺聚糖的发展
  • 批准号:
    10622180
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants
碳水化合物疫苗佐剂的合成与评价
  • 批准号:
    10538831
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants
碳水化合物疫苗佐剂的合成与评价
  • 批准号:
    10642889
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
Strategies for Expedited Synthesis of Sulfated Aminoglycans
硫酸化氨基聚糖的快速合成策略
  • 批准号:
    10371884
  • 财政年份:
    2020
  • 资助金额:
    $ 28.22万
  • 项目类别:
Strategies for Expedited Synthesis of Sulfated Aminoglycans
硫酸化氨基聚糖的快速合成策略
  • 批准号:
    10594458
  • 财政年份:
    2020
  • 资助金额:
    $ 28.22万
  • 项目类别:
Catalytic Methods for Stereoselective 1,2-Cis Glycosylation
立体选择性 1,2-顺式糖基化的催化方法
  • 批准号:
    9163857
  • 财政年份:
    2016
  • 资助金额:
    $ 28.22万
  • 项目类别:
Synthesis and Evaluation of Zwitterionic Carbohydrate Immunostimulants
两性离子碳水化合物免疫增强剂的合成与评价
  • 批准号:
    9109179
  • 财政年份:
    2016
  • 资助金额:
    $ 28.22万
  • 项目类别:
Synthesis of Complex Carbohydrates.
复杂碳水化合物的合成。
  • 批准号:
    8640956
  • 财政年份:
    2012
  • 资助金额:
    $ 28.22万
  • 项目类别:
Tailoring Structures of Sulfated Oligosaccharides for Modulating Heparanase Activity
用于调节乙酰肝素酶活性的硫酸低聚糖的剪裁结构
  • 批准号:
    10164799
  • 财政年份:
    2012
  • 资助金额:
    $ 28.22万
  • 项目类别:
Tailoring Structures of Sulfated Oligosaccharides for Modulating Heparanase Activity
用于调节乙酰肝素酶活性的硫酸低聚糖的剪裁结构
  • 批准号:
    9816301
  • 财政年份:
    2012
  • 资助金额:
    $ 28.22万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 28.22万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 28.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了